Inventor · disambiguated record
Kyle Marvin Trudeau
Also filed as: TRUDEAU KYLE MARVIN
4 granted patents·16 pending applications·14 citations·filing 2016–2025
69Inventor score
Top patents by PatentIndex Score
20 records- 0189US11576872B2Compositions for facilitating membrane fusion and uses thereofFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2018·Granted Feb 14, 2023·12 cites·40 claims
- 0283US2025114406A1Methods and compositions relating to chondrisomes from blood productsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2024·Application pending·0 cites
- 0383US2024390427A1Methods and compositions relating to chondrisomes from cultured cellsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2024·Application pending·0 cites
- 0478US11903974B2Methods and compositions relating to chondrisomes from cultured cellsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2016·Granted Feb 20, 2024·1 cites·27 claims
- 0578US11903975B2Methods and compositions relating to chondrisomes from blood productsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2016·Granted Feb 20, 2024·1 cites·26 claims
- 0675US2022160784A1Methods and compositions of chondrisomesFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2022·Application pending·0 cites
- 0770US2019374582A1Methods and compositions of chondrisomesFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Application pending·0 cites
- 0868US12496274B2Compositions and methods for compartment-specific cargo deliveryFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Granted Dec 16, 2025·0 cites·17 claims
- 0968US2024033227A1Compositions for facilitating membrane fusion and uses thereofFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2023·Application pending·0 cites
- 1062US2025333469A1Use of cd8-targeted viral vectorsSANA BIOTECHNOLOGY INC·Filed 2025·Application pending·0 cites
- 1162US2025281536A1Cd4-specific antibody constructs and compositions and uses thereofSANA BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 1257US2022241328A1Use of cd8-targeted viral vectorsSANA BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 1357US2024408192A1Modified paramyxoviridae attachment glycoproteinsSANA BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 1457US2025152709A1Cd3-targeted lentiviral vectors and uses thereofSANA BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 1557US2025059239A1Modified paramyxoviridae fusion glycoproteinsSANA BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 1652US2021353543A1Targeted lipid particles and compositions and uses thereofSANA BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 1752US2024279685A1Methods and compositions for producing viral fusosomesFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Application pending·0 cites
- 1848US2021228627A1Fusosome compositions and uses thereofFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Application pending·0 cites
- 1947US2021137839A1Compositions and methods for membrane protein deliveryFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Application pending·0 cites
- 2046US2021187018A1Cytobiologics and therapeutic uses thereofFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kyle Marvin Trudeau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →